Studies have shown that breast cancer cells activate autophagy in response to palbociclib, possibly through the inhibition of cyclin D1 expression, and the combination of autophagy and CDK4/6 inhibitors induces irreversible growth inhibition and senescence in vitro (Vijayaraghavan et al., 2017b). This evidence concerns the gene CDK4 and breast carcinoma.